# A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-12-month-dose-level-blinded-safety-and-efficacy-study-of-levodopa-inhalation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric S. Farbman,Cheryl Waters,Peter A. LeWitt,Monika Rudzińska,Michael Klingler,Angela Lee,Jenny Qian,Charles Oh,Robert A. Hauser |
| Citations | 26 |
| DOI | 10.1016/j.parkreldis.2020.10.029 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.prd-journal.com/article/S1353802020308221/pdf |
| OpenAlex ID | https://openalex.org/W3092905706 |
| PMID | 33130477 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jenny Qian](https://scholariq.org/researchers/jenny-qian/)

## Paper journal

- [Parkinsonism & Related Disorders](https://scholariq.org/journals/parkinsonism-and-related-disorders/)

## Paper primary topic

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Paper topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.